Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsGeneral adult psychiatry — personality disorders

Psych MEQs / SAQs · General adult psychiatry — personality disorders

Avoidant personality disorder — criteria, differentials and stepped care (MEQ)

FRANZCP-style modified essay on avoidant personality disorder: DSM criteria, SAD continuum, schizoid/ASD differentials, post-rejection risk, CBT/schema plan, SSRI for comorbidity.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 28-year-old software engineer is referred for 'social phobia and possible personality issues.' Since adolescence he has avoided meetings, refused promotion that would require presenting, and delayed dating because he is 'sure people will find me awkward and reject me.' He wants friends but has only online contacts. He drinks four standard drinks before rare work social events. After a critical email from his manager he took an impulsive overdose of 12 ibuprofen tablets, then called a friend. He scores high on social anxiety screens; developmental history does not suggest autism spectrum disorder. (i) State working diagnosis with operational criteria and justify dual diagnosis decisions. (ii) List key differentials with discriminators. (iii) Outline risk assessment priorities after the overdose. (iv) Propose a medium-term psychological treatment plan with named ingredients. (v) State principles of pharmacotherapy with one named agent, dose, route, monitoring and review. (20 marks)

Model answer

Reveal model answer

(i) Working diagnosis. Avoidant personality disorder (DSM-5-TR): general PD criteria plus ≥4 of 7 features — occupational avoidance of interpersonal contact for fear of criticism, restraint/avoidance of intimacy for fear of shame, preoccupation with rejection, inhibition from inadequacy, self-view as socially inept/inferior, reluctance to take personal risks — present from adolescence, pervasive, impairing. Concurrent social anxiety disorder is justified if marked fear of scrutiny with avoidance/endurance under distress meets duration and impairment thresholds (dual diagnosis common on the continuum). Screen and document major depressive episode given the overdose context. Alcohol misuse as a social safety behaviour is part of the formulation.[1][2]

(ii) Differentials with discriminators. Pure performance-only SAD without pervasive inadequacy schema (his pattern is broader). Schizoid PD (low desire for relationships vs his stated desire for friends). ASD (developmental social communication differences, restricted/repetitive patterns — history argues against). Dependent PD (submissive care-seeking more than evaluation fear). Major depression as primary (episode course vs lifelong pattern — can be comorbid). Body dysmorphic disorder if appearance-focused. Organic/late-onset change (not fitting age of onset here).[1][2]

(iii) Risk after overdose. Medical clearance status; intent at the time vs current intent; plan and means; lethality of 12 ibuprofen (often low medical lethality but psychiatric seriousness remains); trigger (critical evaluation); protective factors (called a friend); hopelessness; depression symptoms; alcohol; access to further tablets; isolation; capacity for discharge decisions; collaborative safety plan and means restriction; least-restrictive disposition with rapid follow-up rather than pejorative dismissal.[1]

(iv) Psychological plan. Alliance-first CBT: shared formulation of inadequacy beliefs → anticipatory anxiety → avoidance/safety behaviours (including pre-event alcohol) → confirmation of fears. Build graded hierarchy (emails → brief meetings → presentations → social gatherings). Behavioural experiments; drop safety behaviours; cognitive restructuring of mind-reading rejection; social skills practice only if true deficits. If global defectiveness schemas dominate, add/switch toward schema therapy — cite Bamelis multicentre RCT effectiveness for PD including Cluster C-relevant samples. Address alcohol with motivational work linked to exposure goals. Measurement (e.g. SPIN/LSAS-style severity + depression scale).[2][3][5]

(v) Pharmacotherapy principles. No drug treats AVPD as a whole. For comorbid generalised social anxiety and/or depression, first-line SSRI is appropriate alongside CBT. Example: sertraline 50 mg orally once daily, early review (1–2 weeks) for activation and suicidality, titrate toward 50–150 mg daily as tolerated with response review at 6–12 weeks; counsel sexual side effects and discontinuation; limited dispensing post-overdose. Avoid chronic benzodiazepines as the social solution. Stop/review dates and measurement-based care.[4][5]

Common errors

  • Collapsing everything into “just shy” without operational criteria.
  • Equating AVPD with schizoid low desire.
  • Automatic long admission for every low-lethality overdose without formulation.
  • Starting three psychotropics without psychotherapy.
  • Claiming no effective treatments exist. [1][2]

Examiner notes

Full marks require ≥4/7 criteria language, dual SAD decision reasoning, desire-based schizoid discriminator, post-rejection risk, named CBT ingredients, schema trial awareness, and a named SSRI with dose/monitoring framed as comorbidity treatment.[1][3][4]

References

  1. [1]Lampe L, Malhi GS Avoidant personality disorder: current insights Psychol Res Behav Manag, 2018.PMID 29563846
  2. [2]Weinbrecht A, Schulze L, Boettcher J, Renneberg B Avoidant Personality Disorder: a Current Review Curr Psychiatry Rep, 2016.PMID 26830887
  3. [3]Bamelis LL, Evers SM, Spinhoven P, Arntz A Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders Am J Psychiatry, 2014.PMID 24322378
  4. [4]Van Ameringen MA, Lane RM, Walker JR, Bowen RC, et al. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study Am J Psychiatry, 2001.PMID 11156811
  5. [5]Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, et al. Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis Lancet Psychiatry, 2014.PMID 26361000